Hopeful drug trial aims to ease dangerous throat scarring
NCT ID NCT05153668
Summary
This small, early study tested if the drug everolimus could help people with a rare condition where dangerous scar tissue narrows the windpipe (called idiopathic subglottic stenosis). The goal was to see if the drug could help patients go longer between surgeries to reopen their airway. Eight adults who had already undergone a specific throat procedure participated in this proof-of-concept trial at Johns Hopkins University.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC SUBGLOTTIC TRACHEAL STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Outpatient Center
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.